IL-1β may participate in NLRP3 inflammasome-mediated tumor promotion in the tumor microenvironment since recombinant IL-1β treatment of macrophages increased the migration and invasion of melanoma cancer cells (Lee et al. 2019a). The gene discussed is NLRP3; the disease is neoplasm.